STK32C

Across TCGA pan-cancer cohorts, STK32C RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated STK32C data layer compared with 5 for mutation status and 5 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher STK32C RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated STK32C expression acts as an unfavorable survival marker, although some lineages such as SCLC and THYM show a favorable association.

KIRC, UCEC, and LIHC are the cancer types where STK32C RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.556	0.686	<.001	124	view →
UCEC	DFS	Tertile	All	0.760	0.874	.001	88	view →
LIHC	OS	Median	All	0.598	0.771	<.001	66	view →
ACC	DFS	Median	All	0.260	0.659	<.001	62	view →
SCLC	DFS	Tertile	II,III,IV	0.809	0.391	.002	59	view →
LAML	DFS	Quartile	All	0.321	0.675	<.001	42	view →
COAD	DFS	Median	All	0.397	0.696	.002	27	view →
SKCM	OS	Median	All	0.738	0.823	.001	25	view →
UCS	DFS	Tertile	IV	0.239	0.978	.024	24	view →
KIRP	DFS	Quartile	III,IV	0.103	0.550	.006	20	view →
THYM	OS	Median	All	0.967	0.728	.002	18	view →
DLBC	DFS	Tertile	All	0.805	0.296	.003	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

STK32C–KIRC (DFS)

Open the KIRC breakdown →